News Daily News Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention Michael O'Riordan March 30, 2022
News Daily News Early Aspirin Tied to Less In-Hospital Mortality in Moderate COVID-19 Todd Neale March 25, 2022
News Daily News Myocarditis Risk Remains Rare After Third mRNA Vaccine Dose Todd Neale March 23, 2022
News Daily News REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19 Todd Neale March 22, 2022
News Daily News More Evidence Links Breast Arterial Calcification and CVD Risk L.A. McKeown March 15, 2022
News Daily News Antithrombotics Not Worth the Risk During Endovascular Stroke Therapy Todd Neale March 07, 2022
News Daily News Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis Yael L. Maxwell March 01, 2022
News Daily News FDA Approves Empagliflozin for Treatment of HFpEF Michael O'Riordan February 24, 2022
News Daily News Fewer Diabetic Complications Seen When NOACs Given for AF L.A. McKeown February 22, 2022
News Daily News No Increased Bleeding With Alteplase in Stroke Patients on DOACs: Registry Data Yael L. Maxwell February 15, 2022
News Conference News ISC 2022 CHOICE: Intra-arterial tPA Enhances Benefit of Stroke Thrombectomy Todd Neale February 11, 2022
News Conference News ISC 2022 ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis Todd Neale February 10, 2022
News Daily News Optimal Medical Therapy for Stable Angina: Which Drugs? How Long? Michael O'Riordan January 25, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022
News Daily News Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S Caitlin E. Cox January 07, 2022
News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021